| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |